Innovations platform

en

In response to IIMCB growing potential, a separate unit was established in March 2010 to deal with applied technology generated at IIMCB, referred to as the Bio&Technology Innovations Platform (BioTech-IP). At the beginning of its existence, the unit organised a series of training courses on the funding paths of science-industry cooperation, negotiations in business, R&D project management, raising a company, the commercialisation of R&D results, and intellectual property rights. It initiated a programme for IIMCB scientists to perform 1- to 2-month internships at pharmaceutical and biotech companies to enable them to sense the entrepreneurial spirit and establish closer links with business partners. These activities are very important to encourage scientists to undertake applied research projects. BioTech-IP has managed to secure funds for pending patent applications.

Presently, Biotech-IP’s job is to find, protect, and commercialise projects that have market potential. With REGPOT funding, employing IPR/tech transfer experts is planned to deal with the applied R&D outcomes of the FishMed projects that are crucial for securing new products and technologies that may stem from them. To develop the long-term process of technology transfer, BioTech-IP needs to be assisted in “hard” skills, such as proper technology assessment and market evaluation for a given invention. This can be achieved through the assistance of experienced specialists with international expertise in the legal and financial aspects of dealing with technology, such as technology assessment, patent law, market research, and license agreement drafting, etc. Having on-board experts on international IP issues is important because the IP generated by the FishMed Centre will be created with European twinning partners. Such experts will complement the BioTech-IP staff, who will then be able to continue professional support for FishMed Centre scientists to identify the innovation potential of their research, help protect their IP rights, locate the funds needed to move to the commercial phase, and secure long-term gains for society.

Commercialisation is a long process that normally takes more than the 3 years to complete, but to plan activities well in advance is a crucial element in forming the groundwork for long-term innovation that will be beneficial for the region and entire EU and will last beyond the project time span. We plan up to three filed patent applications, several reports on technology evaluations or license agreements, business-to-science brunches, and two training courses on IPR and related issues delivered to Centre scientists to further foster their interest and focus on applied research.

Read more:
http://www.biotech-ip.pl/en

YouTube